Bank of New York Mellon’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$326K Sell
290,652
-1,103
-0.4% -$1.24K ﹤0.01% 3732
2025
Q1
$231K Sell
291,755
-1,251
-0.4% -$988 ﹤0.01% 3806
2024
Q4
$483K Sell
293,006
-6,280
-2% -$10.4K ﹤0.01% 3526
2024
Q3
$1.05M Sell
299,286
-74,846
-20% -$262K ﹤0.01% 3112
2024
Q2
$1.23M Buy
374,132
+72,139
+24% +$237K ﹤0.01% 3072
2024
Q1
$2.22M Sell
301,993
-19,959
-6% -$146K ﹤0.01% 2710
2023
Q4
$1.2M Buy
321,952
+9,164
+3% +$34.3K ﹤0.01% 3089
2023
Q3
$663K Sell
312,788
-10,852
-3% -$23K ﹤0.01% 3399
2023
Q2
$1.54M Sell
323,640
-31,552
-9% -$150K ﹤0.01% 2970
2023
Q1
$2.02M Sell
355,192
-7,882
-2% -$44.9K ﹤0.01% 2797
2022
Q4
$3.66M Sell
363,074
-27,195
-7% -$274K ﹤0.01% 2515
2022
Q3
$8.75M Buy
390,269
+39,739
+11% +$891K ﹤0.01% 1970
2022
Q2
$8.69M Sell
350,530
-4,419
-1% -$110K ﹤0.01% 2024
2022
Q1
$13.8M Sell
354,949
-3,446
-1% -$134K ﹤0.01% 1894
2021
Q4
$21M Buy
358,395
+15,085
+4% +$883K ﹤0.01% 1701
2021
Q3
$20.3M Buy
343,310
+15,842
+5% +$939K ﹤0.01% 1717
2021
Q2
$28.4M Buy
327,468
+23,128
+8% +$2.01M 0.01% 1527
2021
Q1
$25.1M Sell
304,340
-10,883
-3% -$897K 0.01% 1569
2020
Q4
$28.7M Sell
315,223
-1,036
-0.3% -$94.2K 0.01% 1408
2020
Q3
$12.6M Buy
316,259
+32,774
+12% +$1.31M ﹤0.01% 1723
2020
Q2
$9.73M Sell
283,485
-16
-0% -$549 ﹤0.01% 1854
2020
Q1
$6.3M Buy
283,501
+44,992
+19% +$999K ﹤0.01% 1956
2019
Q4
$4.67M Buy
238,509
+19,993
+9% +$391K ﹤0.01% 2373
2019
Q3
$3.39M Sell
218,516
-13,139
-6% -$204K ﹤0.01% 2468
2019
Q2
$4.7M Sell
231,655
-19,232
-8% -$390K ﹤0.01% 2361
2019
Q1
$4.41M Buy
250,887
+5,375
+2% +$94.4K ﹤0.01% 2394
2018
Q4
$3.15M Sell
245,512
-21,263
-8% -$273K ﹤0.01% 2514
2018
Q3
$4.35M Sell
266,775
-23,754
-8% -$387K ﹤0.01% 2471
2018
Q2
$3.29M Buy
290,529
+13,839
+5% +$157K ﹤0.01% 2589
2018
Q1
$2.7M Buy
276,690
+124,201
+81% +$1.21M ﹤0.01% 2653
2017
Q4
$931K Sell
152,489
-448
-0.3% -$2.74K ﹤0.01% 3284
2017
Q3
$606K Sell
152,937
-4,609
-3% -$18.3K ﹤0.01% 3485
2017
Q2
$511K Buy
157,546
+98,036
+165% +$318K ﹤0.01% 3586
2017
Q1
$271K Buy
59,510
+952
+2% +$4.34K ﹤0.01% 3779
2016
Q4
$147K Sell
58,558
-2,572
-4% -$6.46K ﹤0.01% 3957
2016
Q3
$191K Sell
61,130
-7,314
-11% -$22.9K ﹤0.01% 3902
2016
Q2
$117K Buy
68,444
+4,941
+8% +$8.45K ﹤0.01% 4019
2016
Q1
$114K Buy
63,503
+75
+0.1% +$135 ﹤0.01% 3935
2015
Q4
$213K Hold
63,428
﹤0.01% 3830
2015
Q3
$338K Buy
63,428
+21,662
+52% +$115K ﹤0.01% 3694
2015
Q2
$270K Buy
41,766
+3,323
+9% +$21.5K ﹤0.01% 3809
2015
Q1
$188K Hold
38,443
﹤0.01% 3905
2014
Q4
$193K Hold
38,443
﹤0.01% 3894
2014
Q3
$196K Hold
38,443
﹤0.01% 3894
2014
Q2
$242K Buy
38,443
+43
+0.1% +$271 ﹤0.01% 3792
2014
Q1
$374K Buy
+38,400
New +$374K ﹤0.01% 3658